About CYGNOS BIOTECH, LLC
CYGNOS Biotech, LLC is a biotechnology company based in South Florida, developing antiviral and oncology therapeutics using a 'One Health' model. The company was founded in 2023 and is focused on creating innovative biologic treatments for both animals and humans.
Development of antiviral therapeuticsOncology drug developmentIn vitro experimentationPilot clinical studies in animals
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| THE PURPOSE OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II CONTRACT IS TO SHOW EFFICACY OF ANTI-VI | Department of Defense | $1.4M | |
| RESEARCH TO CREATE A CLASS OF AGNOSTIC DRUGS TARGETING THE HOST TO ASSIST IN FIGHTING OFF A BROAD SPECTRUM OF | Department of Defense | $204K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CYGNOS BIOTECH, LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.